ESR1 and breast carcinoma: Interestingly, OTUD7B is also known to stabilize estrogen receptor α (ERα), and its depletion results in degradation of ERα and suppression of 17β-estradiol (E2) signaling in breast cancer cells (Fig. 3B) (73).